| European Case Law Identifier: | ECLI:EP:BA:2005:T059101.20050316 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 16 March 2005 | ||||||||
| Case number: | T 0591/01 | ||||||||
| Application number: | 90906651.6 | ||||||||
| IPC class: | A61K 31/34 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Stable ascorbic acid compositions | ||||||||
| Applicant name: | DUKE UNIVERSITY | ||||||||
| Opponent name: | Société anonyme dite: L'OREAL BIODERM, INC. Cellex-C Cosmaceuticals, Inc. |
||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Main request and first auxiliary request: novelty (no) the feature"topic" cannot serve to distinguish the claimed composition from identical compositions used in the state of the art for administration per os Second and third auxiliary requests: inventive step (no)- inclusion of a second, commonly used pharmaceutically accepted carrier into aqueous solutions of a known medicament cannot render the use known per os of such modified solutions inventive |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t010591eu1.html
Date retrieved: 17 May 2021
